Research groups
Alex Gordon-Weeks
MBChB, BSc, DPhil, FRCS
Consultant Liver and Pancreas Surgeon
- Clinical Lecturer in Cancer biology
- Co-lead, Advanced Cancer Models and Therapeutics Group
Research Interests
Spatial biology of primary and metastatic liver cancers.
Hemi-liver perfusion as a novel liver cancer model.
Radiomics for cancer prognostication.
Regulation of tumour immunity.
Clinical Interests
I work as an NHS surgeon within the University of Oxford Hospitals NHS Foundation Trust. I chair the advanced liver cancer multidisciplinary team meeting held at the Churchill Hospital site. The focus of my practice is malignant and benign hepatobiliary pathology inclusive of:
Primary and metastatic liver cancers.
Pancreatic cancer.
Cholangiocarcinoma.
Awards
2025 CRUK Discovery Programme Award
2022 CRUK Cancer Development Fund
2022 Lee Placito Clinical Fellowship Award
Recent publications
Long-term Outcomes Following Resection of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasm (A-IPMN) Versus Pancreatic Ductal Adenocarcinoma (PDAC): A Propensity-score Matched Analysis.
Journal article
Lucocq J. et al, (2025), Ann Surg, 282, 1034 - 1044
Laparoscopic versus open liver resection in patients aged at least 80 years: retrospective propensity score-matched cohort study.
Journal article
Gómez-Gavara C. et al, (2025), BJS Open, 9
Iatrogenic Subcapsular Haematoma Leads to 151% Growth of Future Liver Remnant.
Journal article
Fu H. et al, (2025), Cardiovasc Intervent Radiol, 48, 1389 - 1391
Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant.
Journal article
Fergusson JR. et al, (2025), Cell Rep, 44

